ArticlePLOS global public health2025
A latent class analyses of economic stability, medical mistrust, and barriers to care in relation to PrEP awareness in Black communities in Miami, FL.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the U.S., Black communities are disproportionately impacted by HIV due to economic instability, racism, and structural inequities. Among Black residents who participated in a bundled implementation study from November 2019 through March 2020 in HIV high impact communities in Miami, FL this study examines (a) which latent classes are most prevalent based on indicators of economic stability (ES; income, work, housing, zip-code poverty thresholds), medical mistrust (MM), and barriers to care (BAC) and (b) the latent classes in relation to PrEP awareness and speaking with a doctor regarding HIV (e.g., testing, protection, treatment). Among 569 Black residents (mean = 42.4 years) 67% had never heard of PrEP, but 64% had spoken with a doctor about HIV. Four salient classes emerged: Class 1(34.8%) reported the second highest ES, lowest MM and least BAC. Class 2(18.7%) had the lowest ES, low MM and moderate BAC. Class 3(33.0%) exhibited the highest ES, high MM, and no BAC. Class 4(13.5%) had the third highest ES, highest MM, and highest probability for BAC. No significant differences between classes were found for PrEP awareness, but Class 1 had a higher likelihood of a provider conversation about HIV. Despite varying ES, MM levels and BAC, Black residents of HIV high impact communities are not being informed about PrEP. Interestingly, a significant percentage had provider conversations regarding HIV, especially Black residents with the highest ES, least BAC, and lowest MM. These findings also highlight the need for provider conversations with clients that discuss biomedical prevention tools such as PrEP.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.